These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


454 related items for PubMed ID: 9883970

  • 21. Interleukin-6 and soluble interleukin-6 receptor are elevated in large-vessel vasculitis: a cross-sectional and longitudinal study.
    Pulsatelli L, Boiardi L, Assirelli E, Pazzola G, Muratore F, Addimanda O, Dolzani P, Versari A, Casali M, Magnani L, Pignotti E, Pipitone N, Croci S, Meliconi R, Salvarani C.
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):102-110. PubMed ID: 28466804
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners.
    Neidhart M, Müller-Ladner U, Frey W, Bosserhoff AK, Colombani PC, Frey-Rindova P, Hummel KM, Gay RE, Häuselmann H, Gay S.
    Osteoarthritis Cartilage; 2000 May; 8(3):222-9. PubMed ID: 10806050
    [Abstract] [Full Text] [Related]

  • 24. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T, Gladalska A, Stepień H.
    Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
    [Abstract] [Full Text] [Related]

  • 25. High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.
    Horiuchi S, Ampofo W, Koyanagi Y, Yamashita A, Waki M, Matsumoto A, Yamamoto M, Yamamoto N.
    Immunology; 1998 Nov; 95(3):360-9. PubMed ID: 9824498
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-6-type cytokines and their receptors for gene therapy of melanoma.
    Mackiewicz A, Wiznerowicz M, Roeb E, Nowak J, Pawlowski T, Baumann H, Heinrich PC, Rose-John S.
    Ann N Y Acad Sci; 1995 Jul 21; 762():361-73; discussion 373-4. PubMed ID: 7668537
    [Abstract] [Full Text] [Related]

  • 27. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid.
    Desgeorges A, Gabay C, Silacci P, Novick D, Roux-Lombard P, Grau G, Dayer JM, Vischer T, Guerne PA.
    J Rheumatol; 1997 Aug 21; 24(8):1510-6. PubMed ID: 9263143
    [Abstract] [Full Text] [Related]

  • 28. A gain of function polymorphism in the interleukin 6 receptor influences RA susceptibility.
    Marinou I, Walters K, Winfield J, Bax DE, Wilson AG.
    Ann Rheum Dis; 2010 Jun 21; 69(6):1191-4. PubMed ID: 19713205
    [Abstract] [Full Text] [Related]

  • 29. Expression of members of the interleukin-6 family of cytokines and their receptors in human pituitary and pituitary adenomas.
    Hanisch A, Dieterich KD, Dietzmann K, Lüdecke K, Buchfelder M, Fahlbusch R, Lehnert H.
    J Clin Endocrinol Metab; 2000 Nov 21; 85(11):4411-4. PubMed ID: 11095488
    [Abstract] [Full Text] [Related]

  • 30. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
    Nakahara H, Song J, Sugimoto M, Hagihara K, Kishimoto T, Yoshizaki K, Nishimoto N.
    Arthritis Rheum; 2003 Jun 21; 48(6):1521-9. PubMed ID: 12794819
    [Abstract] [Full Text] [Related]

  • 31. Alternative splicing and proteolytic rupture contribute to the generation of soluble IL-6 receptors (sIL-6R) in rheumatoid arthritis.
    Lamas JR, Rodríguez-Rodríguez L, Tornero-Esteban P, Villafuertes E, Hoyas J, Abasolo L, Varadé J, Alvarez-Lafuente R, Urcelay E, Fernández-Gutiérrez B.
    Cytokine; 2013 Mar 21; 61(3):720-3. PubMed ID: 23375120
    [Abstract] [Full Text] [Related]

  • 32. The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis.
    Oelzner P, Franke S, Lehmann G, Eidner T, Hein G, Wolf G.
    Rheumatol Int; 2012 Jan 21; 32(1):199-206. PubMed ID: 20821212
    [Abstract] [Full Text] [Related]

  • 33. Interleukin 6 and its soluble receptor are elevated in aqueous humor of patients with uveitis.
    Petrinović-Doresić J, Mazuran R, Henc-Petrinović L, Kuzmanović B, Jovicić A.
    Ocul Immunol Inflamm; 1999 Jun 21; 7(2):75-84. PubMed ID: 10420202
    [Abstract] [Full Text] [Related]

  • 34. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients.
    Tsirpanlis G, Chatzipanagiotou S, Boufidou F, Kordinas V, Alevyzaki F, Zoga M, Kyritsis I, Ioannou D, Fatourou A, Nicolaou C.
    Am J Nephrol; 2005 Jun 21; 25(5):484-90. PubMed ID: 16127269
    [Abstract] [Full Text] [Related]

  • 35. Clodronate treatment reduces serum levels of interleukin-6 soluble receptor in Paget's disease of bone.
    Rendina D, Postiglione L, Vuotto P, Numis FG, Di Domenico G, Viceconti R, Mossetti G, Nunziata V.
    Clin Exp Rheumatol; 2002 Jun 21; 20(3):359-64. PubMed ID: 12102472
    [Abstract] [Full Text] [Related]

  • 36. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
    Karczewska-Kupczewska M, Adamska A, Nikołajuk A, Otziomek E, Górska M, Kowalska I, Strączkowski M.
    Clin Endocrinol (Oxf); 2013 Dec 21; 79(6):812-6. PubMed ID: 23199226
    [Abstract] [Full Text] [Related]

  • 37. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.
    Aboulghar MA, Mansour RT, Serour GI, El Helw BA, Shaarawy M.
    Eur J Obstet Gynecol Reprod Biol; 1999 Nov 21; 87(1):81-5. PubMed ID: 10579621
    [Abstract] [Full Text] [Related]

  • 38. Serum levels of IL-6 and its soluble receptor (sIL-6R) in Waldenström's macroglobulinemia.
    Hatzimichael EC, Christou L, Bai M, Kolios G, Kefala L, Bourantas KL.
    Eur J Haematol; 2001 Jan 21; 66(1):1-6. PubMed ID: 11168500
    [Abstract] [Full Text] [Related]

  • 39. Gene expression of receptors for IL-6, LIF, and CNTF in regenerating skeletal muscles.
    Kami K, Morikawa Y, Sekimoto M, Senba E.
    J Histochem Cytochem; 2000 Sep 21; 48(9):1203-13. PubMed ID: 10950877
    [Abstract] [Full Text] [Related]

  • 40. Serum Levels of Interleukin-8 and Soluble Interleukin-6 Receptor in Patients with Stage-I Multiple Myeloma: A Case-Control Study.
    Kohsari M, Khadem-Ansari MH, Rasmi Y, Sayyadi H.
    Asian Pac J Cancer Prev; 2020 Jan 01; 21(1):127-132. PubMed ID: 31983174
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.